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Abstract
The Anopheles gambiae immune response against Plasmodium falciparum, an etiological agent of human malaria, has been
identified as a source of potential anti-Plasmodium genes and mechanisms to be exploited in efforts to control the malaria
transmission cycle. One such mechanism is the Imd pathway, a conserved immune signaling pathway that has potent anti-P.
falciparum activity. Silencing the expression of caspar, a negative regulator of the Imd pathway, or over-expressing rel2,a n
Imd pathway-controlled NFkappaB transcription factor, confers a resistant phenotype on A. gambiae mosquitoes that
involves an array of immune effector genes. However, unexplored features of this powerful mechanism that may be
essential for the implementation of a malaria control strategy still remain. Using RNA interference to singly or dually silence
caspar and other components of the Imd pathway, we have identified genes participating in the anti-Plasmodium signaling
module regulated by Caspar, each of which represents a potential target to achieve over-activation of the pathway. We also
determined that the Imd pathway is most potent against the parasite’s ookinete stage, yet also has reasonable activity
against early oocysts and lesser activity against late oocysts. We further demonstrated that caspar silencing alone is
sufficient to induce a robust anti-P. falciparum response even in the relative absence of resident gut microbiota. Finally, we
established the relevance of the Imd pathway components and regulated effectors TEP1, APL1, and LRIM1 in parasite
infection intensity-dependent defense, thereby shedding light on the relevance of laboratory versus natural infection
intensity models. Our results highlight the physiological considerations that are integral to a thoughtful implementation of
Imd pathway manipulation in A. gambiae as part of an effort to limit the malaria transmission cycle, and they reveal a variety
of previously unrecognized nuances in the Imd-directed immune response against P. falciparum.
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Introduction
Malaria remains one of the world’s most devastating infectious
diseases, and its successful control will require a multifaceted
approach involving a combination of multiple strategies [1,2]. A
multitude of potential methods to prevent mosquito-to-human
transmission exist, including several based on manipulating the
mosquito’s immune response. Despite the lack of an adaptive
immune system, mosquitoes are able to quickly and efficiently
mount an innate immune response against bacteria, viruses, fungi,
and parasites, including Plasmodium. In fact, such an immune
response is responsible for one of the most dramatic reductions in
the parasite population during the Plasmodium life-cycle: a log-fold
loss in parasite numbers as ookinetes cross the mosquito’s midgut
cells and develop into oocysts. This drop in parasite number is due,
at least in part, to an effective cellular and systemic anti-Plasmodium
immune assault. Boosting the mosquito’s immune response to a
level that would fully eliminate this already vulnerable parasite
stage could effectively terminate the malaria transmission cycle.
Immune signaling pathways are key regulators of insect immune
defenses and are therefore attractive candidates for genetic
modification to create a mosquito with an immune response that
overwhelms the parasite. Although the Toll and Jak-Stat pathways
control immune attacks that limit the development of P. berghei, P.
falciparum, and/or P.vivax [3–6], the immune deficiency (Imd)
signaling pathway has emerged as the most effective pathway in
terms of activity against the human malaria parasite. We have
previously shown that over-activating the Imd pathway by
silencing the gene encoding its negative regulator, Caspar, or
over-expressing the gene encoding the REL2 transcription factor
confers almost complete protection from cultured P. falciparum in
laboratory reared A. gambiae, A. stephensi, and A. albimanus; others
have observed a requirement for PGRP-LC, one of the receptors
activating the Imd pathway, in the response of wild-caught A.
gambiae to field isolates of P. falciparum, and still others have
reported a role for REL2, in the response of the recently colonized
Ngousso A. gambiae strain to NF54 P. falciparum [4,7–9]. Thus, the
PLoS Pathogens | www.plospathogens.org 1 June 2012 | Volume 8 | Issue 6 | e1002737Imd pathway has emerged as a critical factor in the ability of
malaria-transmitting mosquitoes to kill P. falciparum, and this
influence is translatable from laboratory to field, most likely across
multiple Anopheles species and Plasmodium strains.
We have shown that an early activation of the REL2
transcription factor in the midgut tissue, at 6–14 hours after
ingestion of an infected blood meal is affective at targeting P.
falciparum [10]. A snapshot of the mosquito’s global gene
regulation, potentiated by over-activation of the Imd pathway
(via caspar silencing), indicated that thioester-containing protein 1
(TEP1), fibrinogen immunolectin 9 (FBN9), and a leucine-rich
repeat family member (LRRD7/APL2) are three of the major
players in the Plasmodium killing that occurs in caspar-silenced
mosquitoes of the A. gambiae Keele strain [4,10]. In addition,
another leucine-rich repeat family member, APL1A, was identified
as a REL2-controlled antiplasmodial effector in the Ngousso strain
[8]. These genomic and functional studies of downstream effectors
mediating the Imd-dependent infection phenotypes have provided
important mechanistic insights and have encouraged the hypoth-
esis that vector control methods targeting the Imd pathway are
inherently multifaceted at the effector level. However, the high
degree of biological complexity that characterizes the vector-
parasite interaction requires a deeper understanding of Imd
pathway-directed killing of Plasmodium at the physiological level.
In this study, we addressed some of the remaining key questions
regarding the impact of the Imd pathway on P. falciparum infection
in the A. gambiae Keele strain, with the goal of facilitating the
identification of optimal strategies for Imd pathway manipulation.
We first addressed the contribution of specific Imd pathway
components in the anti-Plasmodium defense. Existing data have
implicated the negative regulator Caspar, the transcription factor
REL2, and the pattern recognition receptor PGRP-LC in the
defense against malaria so we concentrated our efforts on the Imd
pathway components known in Drosophila to interact with or
between these components and that have a clear 1-to-1 ortholog in
Anopheles (Figure 1), though Anopheles immune signaling pathways
do not necessarily mimic those in Drosophila. As examples,
mosquitoes do not have an ortholog of Dif, one of the transcription
factors downstream of the Toll pathway in Drosophila [11], Anopheles
possesses two functional isoforms of REL2, while flies have only
one [12] and TAB2 does not have a reliable ortholog in A. gambiae.
We specifically sought to identify the range of Imd pathway genes
that have an impact on P. falciparum infection, so we assessed the
contribution of each potential pathway member to both the
Figure 1. Anopheles Imd pathway model. Components of the Imd pathway explored in this study or others are represented by different colored
shapes. Black arrows or lines indicate known interactions or translocations. Gray arrows indicate potential interactions based on D. melanogaster
studies. The gray bracketed area indicates the molecules possibly involved in other responses, but not the responses against P. falciparum. Numbers
and arrows within colored blocks indicate the -fold change in P. falciparum infection that results when the corresponding pathway member is
silenced. The list of genes inside the nucleus portion of the diagram shows those known to be active against Plasmodium and whose expression has
been shown by our studies to be REL2-regulated.
doi:10.1371/journal.ppat.1002737.g001
Author Summary
The immune response of the mosquito vector of Plasmo-
dium has proven to possess powerful anti-Plasmodium
defense capabilities. As the major regulators of these
immune responses, signaling pathways, particularly the
Imd pathway which seems especially capable of eliminat-
ing malaria parasites, have become attractive candidates
targets for malaria-control interventions. Although the
general anti-parasitic activity of the Imd pathway has been
established, the particular components of the pathway
involved and the physiological conditions under which the
pathway is capable of limiting infection are mostly
unknown. Awareness of these major players and condi-
tions is crucial for adapting the Imd pathway into an
intervention strategy. We report that while several
members of the Imd pathway are critical for such a
response, others are dispensable. We also show that
timing of the response with regard to infection and
intensity of infection exposure both influence the effec-
tiveness of an Imd-derived anti-Plasmodium response
while the status of the gut flora does not. Taken together,
this data lays the essential groundwork for effective
intervention based on manipulation of this pathway that
can severely limit mosquito infection with human malaria
parasites.
Anopheles Imd Pathway in Anti-Plasmodium Defense
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caspar silencing) immune response against P. falciparum.
We then determined which parasite life-cycle stages are
vulnerable to an Imd pathway-derived attack. After it enters the
midgut lumen, Plasmodium completes its fertilization to form a
zygote, transitions to the motile ookinete form, penetrates the
midgut epithelium, and transforms into the oocyst stage. Since
most assessments of immunity enumerate parasites at the oocyst
stage, it is often unknown which stage(s) are targeted by anti-
Plasmodium mechanisms, yet this information could drastically
affect how an anti-Plasmodium strategy is designed.
It has long been known that mosquitoes’ endogenous bacteria
can affect Plasmodium development [13,14], but a recent cohort of
studies exploring the tripartite interactions between vector,
parasite, and the vector’s intestinal microflora at the molecular
level have revealed complexities that can drastically affect immune
responses and Plasmodium densities in mosquitoes [7,9,15,16]. An
important consideration for any effector mechanism that is acting
against both parasites and bacteria (such as the Imd pathway) is
that its activity may be elicited either directly by the parasite or
indirectly by the proliferation of gut bacteria that occurs
concurrently with blood-feeding, and how that elicitation occurs
is likely to be crucial for intervention planning. This concern is
particularly important for the Imd-driven response to P. falciparum
because gut-specific over-expression of REL2 in A. stephensi has a
significant effect on P. falciparum, highlighting the immune
contribution of tissues harboring bacteria [10]. Therefore, in the
present study we also asked whether bacteria are required for the
effectiveness of caspar silencing in limiting P. falciparum.
To date, all analyses of the effect of the Imd pathway and its
downstream components on P. falciparum infection have utilized an
exceptionally virulent strain of P. falciparum that is capable of
producing high intensities of infection. Recent work from Mendes
et al. [17] has revealed differential gene expression profiles in
mosquitoes that were given higher or lower parasite exposures,
suggesting that the anti-Plasmodium response can vary with the
infection intensity. To assess the potential role the Imd pathway in
this differential response, we also assessed the outcome of infection
following three different levels of parasite exposure in mosquitoes
in which several Imd pathway members and downstream effectors
had been silenced.
Results
Components of the Imd pathway modify the Caspar-
mediated anti-Plasmodium defense
To assess the contributions of Imd pathway components to the
anti-Plasmodium defense, we used an RNA interference approach to
silence individual genes in order to determine whether each was
necessary for P. falciparum infection. A double-silencing assay was
also performed to determine whether those components with an
effect on P. falciparum could reverse the decreased infection that
was observed when caspar was silenced, thereby identifying any
factors that are essential for the caspar silencing-mediated immune
defense in addition to the routine defense against P. falciparum.
Silencing of the Imd pathway factors imd, fadd, caspL1 (dredd),
and rel2 resulted in median P. falciparum oocyst infection intensities
that were at least two-fold greater than those of the control group
treated with dsRNA against GFP (Figure 2A–2D, Table S1). Of
these genes, only silencing of rel2 had a significant effect on
infection prevalence (Figure 2H and Table S1). Co-silencing of the
four pathway members (imd, fadd, caspL1, and rel2) with caspar
completely reversed the typical resistance to infection observed
when only caspar was silenced; i.e., median infection intensities
were not significantly different from those of the single-silenced
groups and did not exhibit the absence of infection typically
observed following caspar silencing (Figure 3) and [4].
Single-silencing of ikk-gamma increased the median number of
oocysts per midgut by 2.3-fold over that of the GFP dsRNA-
treated control mosquitoes, yet co-silencing ikk-gamma with caspar
only partially reversed the caspar-silencing resistance; silencing of
ikk-gamma in conjunction with caspar returned the median infection
intensities to control levels (54% of the single-silencing levels)
(Figure 2E). Similarly, silencing rel2-L increased the median oocyst
load by 2.47-fold and significantly increased prevalence, yet co-
silencing did not reverse the effect of caspar silencing; median
intensities in the rel2-L/caspar-silenced mosquitoes were only 70%
of the control levels (28% of the single-silencing levels) (Figure 2F
and 2H).
Depletion of the TAK1 protein had no significant effect on P.
falciparum infection; median oocyst levels in silenced mosquitoes
reached 22 oocysts per mosquito, nearly identical to the median of
22.5 oocysts per mosquito in GFP dsRNA-treated controls
(Figure 2G). Accordingly, silencing caspar still resulted in significant
repression of P. falciparum intensity and prevalence, even when tak1
was silenced (Figure 2G and 2H). TAK1 is a branch point bridging
the Imd and JNK pathways; therefore, to ensure that caspar is
controlling only the Imd pathway, we assessed how the depletion
of jnk would affect P. falciparum and found no effect (data not
shown).
The Imd pathway is primarily active against P. falciparum
pre-oocyst stages
Although Plasmodium parasites are susceptible to mosquito
immune responses at multiple stages of their development,
previous analyses of caspar silencing have measured only the
changes in oocyst numbers, an approach that cannot distinguish
between activity against a specific stage and that against multiple
stages. To discover which stage(s) of development is (are) halted by
caspar silencing, we developed an assay in which the time of
dsRNA injection was varied. In this assay, peak silencing occurred
only after most parasites had matured to a specific stage. Time
course analysis of caspar silencing revealed that efficient depletion
of caspar mRNA throughout the mosquito body could be achieved
within a day of injection, and the effect would persist for at least 6
days (Figure 3A). Based on this kinetic profile, we administered
dsRNA against caspar or GFP at 3 and 6 days post-infection to
specifically target early and late oocysts, respectively. Previous
analyses of Caspar have utilized silencing at 3 to 4 days pre-
infection, a time at which one can also assess the effect on
ookinetes (Figure 2) [4]. We have also previously shown that over-
expression of REL2 in the midgut tissue following a blood meal
results in the inhibition of pre-ookinete stages and/or killing of
ookinetes in the lumen prior to invasion [10]. We cannot,
however, exclude the possibility that caspar, which is upstream of
REL2, also controls a REL2-independent branch of the Imd
pathway.
Administered 3 days post-infection, caspar silencing significantly
reduced the number of developed oocysts when compared to GFP
dsRNA-treated controls. Although the mosquitoes were not
rendered resistant to infection, prevalence of infection was reduced
by 12.3% and the intensity of infection was still severely reduced:
GFP-dsRNA treated mosquitoes harbored a median 45.5 oocysts
per gut, whereas caspar-silenced mosquitoes harbored only 10.5, a
decrease of 77.3% (Figure 3B, Table S2A). For comparison,
silencing genes encoding negative regulators of the Toll (Cactus)
and Stat (Pias) pathways, two pathways involved in the killing of
parasites [4,5], also had an effect on early oocyst development;
Anopheles Imd Pathway in Anti-Plasmodium Defense
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inhibition, and cactus silencing the weakest (data not shown).
In contrast to treatments affecting the pre- and early oocyst
stages, silencing treatments designed to target the late-oocyst stages
(silencing at 6 days post-infection) were far less effective in limiting
the number of parasites per midgut in caspar-silenced and control
mosquitoes, although, surprisingly, an appreciable degree of
infection inhibition was still observed. In these experiments, the
median number of surviving oocysts in the caspar-silenced
mosquitoes was 36, as compared to 56 in the GFP dsRNA-treated
mosquitoes, representing a decrease of 45.7% while prevalence
was not impacted (Figure 3C, Table S2B).
The Caspar silencing-mediated anti-P. falciparum defense
is independent of the midgut microbiota
Several studies have illuminated the importance of tripartite
interactions between the mosquito’s immune system, the parasite,
and the mosquito’s intestinal flora during Plasmodium infection
[7,9,15,16]. For some anti-parasite gene regulation and killing
mechanisms, the presence and appropriate composition of the
bacterial populations in the gut are required [9,15,16]. In
Drosophila, the Imd pathway is a primary regulator of the response
against intestinal bacteria [18–20], and we have observed that
REL2 over-expression exclusively in the mosquito midgut offers
resistance to parasites [10], leading us to question whether bacteria
are necessary for the activation of the Imd pathway during caspar
silencing, or whether the Imd pathway activation provided by the
bacteria under normal conditions is simply supplanted by the
artificial Imd pathway activation mediated by caspar silencing. To
answer this question, we administered an antibiotic cocktail to
mosquitoes before treating them with dsRNA against caspar or
GFP and subjecting them to P. falciparum infection. We have
previously shown that antibiotics can be used to eliminate the
majority of the bacterial population from the mosquito midgut
[9,21]. As had previously been shown, we found that GFP dsRNA-
treated mosquitoes were more susceptible to Plasmodium infection if
Figure 2. Some members of the Imd pathway have an effect on P. falciparum infection. (A–G) Dots represent individual oocyst counts
following the indicated RNAi treatment; horizontal red bars represent the median number of oocysts per gut. P-values were derived from Mann-
Whitney statistical tests and appear above each treatment and refer to that treatment as compared to the GFP dsRNA-treated control. Additional
statistical analyses appear in Table S1) Filled portion of bars represent the % of all mosquitoes harboring at least one oocyst; open portion represents
those in the group that were uninfected. All assays represent two to three independent biological replicate. Cpr, Caspar. (H) Prevalence of P.
falciparum infection following the indicated RNAi treatment.
doi:10.1371/journal.ppat.1002737.g002
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harbored almost twice as many oocysts as their GFP dsRNA-
treated septic counterparts (Figure 4A, Table S3). However, the
lack of bacteria in antibiotic-treated mosquitoes had no effect on
the ability of caspar silencing to severely limit parasite development;
both septic and aseptic mosquitoes treated with dsRNA against
caspar displayed median oocyst levels of 0 and had much lower
prevalence of infection than did either GFP dsRNA-treated group,
though not significantly different from one another (Figure 4B,
Table S3).
The efficiency of the pro-and anti-parasitic responses
obtained by silencing Imd pathway components and
downstream effectors is dependent on infection intensity
Earlier studies have featured a model system composed of a
highly virulent parasite strain and highly susceptible mosquito
strain. While we have previously shown that the Imd pathway is
effective against P. falciparum in other Anopheles strains [4], recent
data have revealed the importance of infection intensity in the
generation of immune responses directed against Plasmodium [17].
To determine whether Imd-derived responses are more or less
effective against different levels of infection, we subjected
mosquitoes to a standard administration of dsRNA against various
Imd pathway members and downstream effectors; then, at 3 to 4
days after the dsRNA injection, we fed them on P. falciparum-
infected blood with a more dilute or more concentrated
gametocyte culture than that used in the standard protocol.
Oocyst counts indicated that, indeed, low-, medium-, and high-
intensity infections had been achieved, with roughly log-fold
differences (median=1, 7, and 86, respectively) from the levels in
GFP dsRNA- treated control mosquitoes (Figure 5, Tables S4A–
C) and that the infection phenotypes observed following silencing
were not consistent for the three levels of infection intensity
(Figure 5). For example, silencing all forms of apl1 significantly
increased the infection levels (when compared to the GFP dsRNA-
treated group) only at low (a 2-fold increase) and medium (a 2.6 -
fold increase) infection intensities. Specific paralog silencing
suggested that APL1C was most effective in influencing low-level
infections (a 2-fold increase), while APL1B was the most influential
paralog at medium infection intensities (a 2.3-fold increase). In our
experiments, APL1A depletion had no effect on P. falciparum
infection under any condition.
As was seen when we silenced all forms of apl1, knockdown of
another member of the leucine-rich repeat-containing family,
lrrd7, was effective in low- and medium-, but not high-intensity
infections. Importantly, we noted that both the prevalence and
intensity of infection were significantly increased by silencing lrrd7
prior to low levels of exposure to P. falciparum, but only infection
intensity was significantly altered by lrrd7 silencing prior to
medium-level exposure. Thus, the contribution of a gene to the
anti-Plasmodium response is not only dependent on the level of
exposure but also on the method of data collection used (Figure 5
and Tables S4A–C).
Figure 3. Caspar silencing also influences early and late
oocysts. (A) Time course of caspar-silencing efficiency, quantified
using real-time quantitative PCR. Gray bars represent the % caspar
expression at each given time point as an average of two replicates, and
error bars reflect the standard error between those replicates. Cpr,
Caspar. (B) Infection intensity of mosquitoes silenced for caspar at 3
days post-infection (dpi). Since ookinetes invade the midgut at
24 hours post-infection this time point targets early oocysts. (C)
Infection intensity of mosquitoes silenced for caspar at 6 days post-
infection. Since sporozoites begin to emerge from the oocyst at 7–8
days post infection, this time point targets late oocysts. For both, dots
represent individual oocyst counts following the indicated RNAi
treatment; horizontal red bars represent the median number of oocysts
per gut. Assays represent two to three independent biological
replicates and were subject to Mann-Whitney statistical tests. P-values
appear above each treatment and refer to that treatment as compared
to the GFP dsRNA-treated control. Additional statistical analyses appear
in Table S2. Filled portion of bars represent the % of all mosquitoes
harboring at least one oocyst; open portion represents those in the
group that were uninfected. Cpr, Caspar.
doi:10.1371/journal.ppat.1002737.g003
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third LRR-containing effector, LRIM1, during P. falciparum
infection at either low or high intensity. However, we surprisingly
observed that in the context of a medium-level infection, silencing
of LRIM1 did substantially enhance infection (a 3.1-fold increase)
(Figure 5).
Interestingly, silencing the major pathway component, Imd, was
only effective at increasing infection intensities at high infection
levels (a 3.2-fold increase), the level closest to that at which
pathway analysis is typically performed (Figure 5). Nevertheless,
caspar silencing was effective in limiting infection, regardless of the
exposure dose; in essence, caspar silencing was effective in limiting
low-, medium- and high-intensity P. falciparum infections. The only
other tested effector to display this consistent effect was TEP1
(Figure 5).
As a control, we checked the efficiency of the gene silencing of
the Imd pathway components and downstream effectors genes by
measuring the expression of their gene-specific RNAs and
observed a reduction of 48–92% in their regular expression
patterns (Table S5).
Discussion
Despite the fact that the negative regulator of the Imd pathway,
Caspar, controls a branch of the mosquito immune system that
determines the mosquito’s resistance to human malaria parasites,
until now little has been known about the genes/proteins
controlled by this regulator, when they exert their effects on the
parasite, and whether this activity is dependent on a tripartite
relationship with endogenous bacteria or is influenced by infection
intensity. The answers that we have obtained to these essential
questions about the biology of Caspar should facilitate the use of
the Imd pathway for the development of malaria control strategies.
The Imd pathway contains an anti-P. falciparum module
In the present study, we first addressed the contribution of
selected components of the Imd pathway to the normal mosquito
response against P. falciparum (single-silenced and infected) and the
Caspar-controlled response against P. falciparum in relation to other
Imd pathway factors (double-silenced and infected). These
experiments revealed three different phenotypes for Imd pathway
members: 1) full participation in both anti-P. falciparum responses
and caspar-mediated resistance; 2) weaker participation in anti-P.
falciparum responses, with unclear contribution to the response
directed by caspar; and 3) no participation in anti-P. falciparum
immunity.
For the first group of components, silencing genes encoding four
of the known components of the Imd pathway (Imd, FADD,
CaspL1 and REL2) resulted in a significant increase in the
intensity of the midgut infection when compared to GFP dsRNA-
treated controls and an ability to reverse the resistance caused by
caspar silencing. Importantly, co-silencing Imd, FADD, CaspL1,
and REL2 with caspar gave median infection intensities that were
almost identical to those of the single-silenced groups. This result
suggests a complete dependence of the caspar-silenced infection
phenotype on these pathway members. This finding is not
surprising, since Drosophila Caspar has been suggested to regulate
the Dredd-dependent cleavage of REL2, and Imd and FADD are
co-activators of Dredd [22]. Thus, the four components that
produced both the strongest single-silencing phenotype and the
most complete reversion in double-silencing experiments were also
the components that have been hypothesized to interact most
directly with Caspar.
In contrast, the second group of components produced
reasonable increases in infection level in response to single
silencing, yet only a partial reversion of the caspar phenotype.
Reduced levels of IKK-gamma led to an appreciable increase in
oocyst load when compared to control silencing treatments; the
co-silencing of caspar and IKK-gamma showed a mild reversion of
the caspar phenotype, but to levels that were not significantly
elevated over those for the GFP dsRNA-treated control (as was
consistently observed for the four genes in the first group). This
result could suggest either a lesser involvement in caspar-dependent
immune responses than for the other components, a dual role for
Figure 4. Caspar-mediated killing of P. falciparum is not dependent on midgut bacteria. (A) Blue bars represent bacteria colony-forming
unit (CFUs) from midguts of mosquitoes undergoing the indicated treatments. Pluses and minuses indicate the presence or absence of antibiotic in
GFP or Cpr dsRNA treated group. Each bar represents the average of at least 15 mosquitoes tested, with each mosquito’s CFU count determined by
averaging counts from three serial dilutions. Bars represent the standard deviation for all mosquitoes in a given treatment group. Cpr, Caspar. (B) Dots
represent individual oocyst counts following the indicated RNAi treatment; horizontal red bars represent the median number of oocysts per gut.
Pluses and minuses indicate the presence or absence of antibiotic in the GFP or Cpr dsRNA-treated group. Assays represent three independent
biological replicates and were subject to Mann-Whitney statistical tests. P-values appear below each treatment and refer to that treatment as
compared to the GFP dsRNA-treated control. Additional statistical analyses appear in Table S3. Filled portion of bars represent the % of all mosquitoes
harboring at least one oocyst; open portion represents those in the group that were uninfected. Cpr, Caspar.
doi:10.1371/journal.ppat.1002737.g004
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es (the independent form interfering with a complete reversion of
the dependent), or a caspar-independent role in antagonizing P.
falciparum response that overwhelms the agonistic output of Caspar.
REL2-L is also a member of the second group. Experiments in
the Drosophila model system have strongly suggested that Imd
pathway activation results in the cleavage of the ankyrin repeat
region of the C-terminus of Relish, likely by Dredd, freeing the
active form of Relish for translocation to the nucleus [23,24]. In
Anopheles, both a full form of the Relish ortholog (REL2-L) and a
short form lacking ankyrin repeats (REL2-S) are independently
transcribed [12]. Because there are no unique sequences for
targeting only REL2-S with dsRNA, the distinct roles of the two
forms are unclear. However, because the long form can be
Figure 5. Imd pathway components and effectors differ in their ability to affect P. falciparum infections of high, medium, and low
infection intensities. Intensity of P. falciparum oocysts in A. gambiae silenced for given genes and subjected to low (A), medium (C) or high (E)
infection exposures. Bars represent median numbers of oocysts per midgut, and dots represent individual midgut oocyst counts. Assays represent at
least three independent biological replicates and were subject to Mann-Whitney statistical tests. P-values appear above each treatment and refer to
that treatment as compared to the GFP dsRNA-treated control. Non-significant p-values were not included in the figure. Additional statistical analyses
appear in Table S4. D-F: Prevalence of infection in A. gambiae subjected to low (B), medium (D) and high (F) loads of P. falciparum. Filled portion of
bars represent the % of all mosquitoes harboring at least one oocyst; open portion represents those in the group that were uninfected. wAPL1
(whole APL1) dsRNA – dsRNA for a conserved region of APL1 genes, which results in the silencing of all three APL1 proteins (APL1A, APL1B and
APL1C).
doi:10.1371/journal.ppat.1002737.g005
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the region encoding the ankyrin repeats) the contributions of
REL2-L to a phenotype can be quantified independently of the
contributions of all REL2 forms. Mitri and colleagues [8] have
reported that silencing only rel2-L has no effect on the prevalence
of P. falciparum infection, although infection intensities were not
reported in their study. We observed in the present study that
silencing rel2-L had a noticeable effect on oocyst burden in single-
silencing assays but did not result in the same potent immune
response against P. falciparum as did silencing all forms of rel2.I n
addition, while co-silencing of caspar and rel2-L did not result in
complete refractoriness, double-silencing was unable to reverse the
phenotype, even to the level of infection intensity observed for the
GFP dsRNA-treated control group, much less to the single-
silencing levels observed when all forms of rel2 were targeted
(Figure 1D). The inability to target REL2-S leaves the identifica-
tion of distinct roles for the short and long forms still unclear. We
can therefore only conclude that both forms of REL2 are able to
participate in the normal response of A. gambiae to P. falciparum,
with the short form being a major constituent of caspar-mediated
resistance to that parasite and the long form a more minor
component.
The third group of components showed no effect on infection
when either single-silenced or double-silenced and had no effect
on the outcome of caspar silencing. In Drosophila, TAK1 is a kinase
that is able to activate both JNK and IKKg [25,26]. Our data
showed no observable role for TAK1 in the defense against P.
falciparum and no requirement for TAK1 in the caspar-silencing
infection phenotype. Caspar is purported to control the cleavage of
REL2 by CASPL1/Dredd [22]; TAK1’s role is more likely to be
that of an activator/mediator of the branch point between the Imd
and JNK pathways [27–29]. Therefore, TAK1 may be dispens-
able during the activation of REL2 that occurs in caspar-silenced
mosquitoes and, if so, it should not be considered a major target in
future applications. Consistent with this conclusion that TAK1 is
not a major player in anti-P. falciparum responses, our further
investigation into the JNK pathway side of TAK1’s responsibilities
revealed that P. falciparum is unaffected by JNK silencing. Since this
screen is directed toward anti-Plasmodium responses, we cannot
remark on the contributions of TAK1 (or other Imd pathway
genes) during other infections in Anopheles.
Taken together, these data suggest that the proteins hypothe-
sized to act most intimately with Caspar (Imd, FADD, CASPL1,
and REL2) are the most effective players in the mosquito defense
against P. falciparum and that the Imd pathway is uniquely potent
against this parasite. Based on these data, we propose a model of
the A. gambiae Imd pathway (illustrated in Figure 1) in the context
of P. falciparum infection. Since this model was generated on the
basis of data from RNAi-based gene silencing, researchers must
bear in mind the caveats associated with this methodology: i.e., the
extent of the silencing is dependent on the silencing efficiency,
mRNA turnover, tissue specificity of expression, and the ability of
the dsRNAs to reach the appropriate tissues. It is also possible that
additional components not included in this targeted screen are
part of the anti-Plasmodium Imd signaling module; including known
Imd pathway genes not assessed in this screen, unknown genes
serving as novel members or unknown genes serving as a
functional equivalents of known genes (such as TAK1) in
mosquitoes. Nevertheless, the strong infection-intensity pheno-
types obtained by silencing multiple Imd pathway members
suggest that this module within the pathway is a major player in
the anti-P. falciparum defense employed by A. gambiae.
The Imd pathway is primarily active against pre-oocyst P.
falciparum stages
Previous analyses of Caspar and Cactus have utilized a standard
silencing protocol developed to assess immune responses directed
against the ookinete stage of Plasmodium [3,4]. This protocol is
widely used because the ookinete stage represents a bottleneck in
terms of parasite population that is thought to be caused at least in
part by the mosquito’s immune responses. However, depending on
the silencing kinetics of a particular gene, this approach either
ignores immune molecules that are effective at later stages, when
transcript levels of the target gene have recovered, or is unable to
distinguish effects at earlier or later stages because silencing occurs
throughout. These complications were made apparent by a study
that found a role for the Stat pathway against early oocysts but not
ookinetes [5]. Because the silencing of caspar occurs quickly, but
mRNA levels recover within 5 to 6 days (Figure 3A), identifying
the parasite stages affected by the Imd pathway can be achieved by
varying the times at which dsRNA is injected. This method has
revealed that ookinetes are most affected by Imd pathway
activation, resulting in mosquito resistance to the parasites, but
there is also a significant contribution of the pathway to limiting
early oocysts (Figure 3B) [4]. In addition, caspar silencing is weakly,
but significantly, effective in limiting the development of late
oocysts, in agreement with our previous finding that REL2
activation in the midgut tissue also results in the inhibition of late
oocysts, and possibly sporozoite stages, of P. falciparum [10].
Together, these studies indicate that there is an extended
window of opportunity in the parasite lifecycle for the mosquito to
respond to and combat P. falciparum by means of the Imd pathway,
but there is an optimal time of response within that window. We
hypothesize that this timing is the reason that pre-arming the
mosquito with downstream effectors by artificially activating the
Imd pathway through caspar silencing allows the mosquito to
mount a rapid, strong immune response in the midgut epithelium
and hemolymph that is effective in killing the most susceptible
stages of Plasmodium. Under normal conditions, the mosquito must
first sense infection then activate the Imd pathway, at which point
the effectors can respond; the efficiency of killing is reduced as the
time required to complete these steps increases. By silencing caspar,
we can circumvent the detection and activation steps, so the
effector mechanisms are quickly established and at the ready for
early killing, at the most susceptible stage of the parasite. This
hypothesis has been corroborated by our previous study in which
we found that an earlier-than-normal enrichment of the REL2
protein through transgenic over-expression resulted in a profound
decrease in P. falciparum infection [10].
Understanding the importance of timing is clearly crucial for
manipulating this biology in future studies addressing the Imd
pathway as part of an integrated malaria control strategy. The
message from these experiments is that early Imd pathway activity
is preferable, and the pre-ookinete stages are the most vulnerable
to an attack in the midgut tissue [10]. However, such a response
can still be antagonistic to the parasite at later time points in the
lifecycle.
The effect of caspar silencing on P. falciparum is
independent of gut microbiota
Several studies have reported a significant contribution of the
endogenous flora to the generation of a mosquito’s anti-parasitic
responses. In addition to the direct interaction between bacteria
and parasites, the exponential increase in midgut bacterial loads
during blood-feeding elicits immune gene expression and activates
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are present in the lumen and invading the midgut epithelial cells
[21]. These immune mechanisms attack or limit Plasmodium
indirectly but adequately [9,10]. If the resistance to P. falciparum
is not solely due to immune activation operating via manipulation
of Imd pathway expression but is instead dependent on normal
activation of the Imd pathway by bacterial PAMPs (that is merely
augmented by caspar silencing), any control strategy based on the
Imd pathway will be affected by the mosquito’s individual flora.
Detectable infection levels in mosquitoes lacking endogenous
bacteria suggest that the lack of negative regulation in the Imd
pathway is sufficient to confer resistance to P. falciparum. Standard
antibiotic treatments eliminate 99% of the endogenous bacteria
[8,9], but it is possible that PAMPs from dead bacteria or shed
peptidoglycan still exist in antibiotic-treated mosquitoes. Thus, it is
possible that a basal level of bacteria or bacterial components is
required to begin Imd pathway activation, and the lack of negative
regulation perpetuates the up-regulation of anti-microbial effectors
that kill Plasmodium. However, the observation that the required
basal level of elicitation can occur in mosquitoes with ,1% of the
normal flora suggests that the differences in bacterial loads or flora
composition would have only minimal effect on P. falciparum
resistance directed by the Imd pathway.
The anti-Plasmodium activity of individual Imd pathway
components is influenced by infection intensity
By manipulating the dosage of P. falciparum gametocytes
available during blood feeding, we have been able to control the
average infection intensity in a given group of mosquitoes. These
experiments showed that the requirement of a given pathway
component or effector, assessed by RNAi, is often dependent on
that average infection intensity (but not always, as evidenced by
Caspar and Tep1) (Figure 5). Effectors that are known to be
required at higher Plasmodium doses yet seem ineffective at low
doses may not be up-regulated or otherwise activated in control
mosquitoes at lower doses. This hypothesis is supported by recent
transcriptomic data suggesting that, for some immune genes,
expression is dependent on the infection intensity [17]. Alterna-
tively, it is possible that RNAi-based assays are not sufficiently
capable of depleting specific transcripts to have an impact on a
low-intensity infection; this situation would be particularly true for
genes exhibiting a rapid rate of transcription and/or encoding
proteins that have potent anti-Plasmodium effects at low concen-
trations.
Effectors known to be required at lower but not higher doses
could be influenced by a saturation effect, in which Imd pathway
effectors are being produced in quantities that are sufficient to kill
lower numbers of parasites but insufficient to deal with infections
above a certain level. This would be the case if only a small, finite
number of anti-Plasmodium effectors are produced and therefore
available for combating parasites. This type of effector would not
have an effect on infections at high intensities in control
mosquitoes, and therefore silencing the gene(s) that encode them
would show no effect. Inefficiency of some effectors at higher
Plasmodium doses may also be governed by infection-intensity gene
regulation if high levels of infection cause those genes to be down-
regulated, as in, for example, a feedback loop. Such genes would
theoretically be produced at sufficient levels in control mosquitoes
during low- or medium-level infections but would be down-
regulated, and therefore less effective, at higher doses.
Our data suggest that the medium- intensity infection levels are
optimal for studying anti-Plasmodium defenses under laboratory
conditions, since measurable effects can be seen for most genes,
and statistical analyses can be made (in contrast to very low-
infection assays). However, our data also indicate that looking only
at medium-level intensities can lead to unfounded assumptions
about the physiological relevance of the examined genes during
infection under natural field conditions, and complexities of
pathway regulation can be masked.
Our study also offers a number of interesting and novel insights
into other aspects of anti-Plasmodium defenses that have not been
addressed in previous studies using only standard infection
intensities:
First, in our assessment of the requirement for LRIM1,
LRRD7, and all three paralogs of APL1, we found that some
components were necessary for low-, medium- or high-level
infection exposures, but none were required at all levels of
exposure, perhaps reflecting redundancy or shared roles among
this group (Figure 5). How those roles are assigned or regulated
with respect to the number of successful ookinete invasion events
has yet to be determined. Our analysis of the LRR-containing
proteins revealed that the APL1 paralogous genes behaved
differently in our experiments than in those reported by Mitri et
al. [8]. While we confirmed their report of a role for APL1 genes in
limiting P. falciparum, our data are not in agreement with regard to
the specific paralogs involved. Most strikingly, we did not find a
significant role for the APL1A paralog in the anti-P. falciparum
immune response (Figure 5), but we did for APL1B or APL1C,
depending on the intensity of infection. The APL1 gene family has
exhibited a complex sequence evolution, including an exception-
ally high degree of polymorphism in some strains, with a recent
selective sweep occurring in others [30]. Therefore, although our
study confirms a role for APL1 gene family members during P.
falciparum infection, the differences we saw in regard to which
family members are playing the effector role may be explained by
the possibility that we are assaying mosquitoes with different
versions of APL1 sequences, or the fact that all our infection assays
used a significantly higher infection intensity than did those of
Mitri et al.
Second, the results of infection exposure have revealed a novel
role for LRIM1 during P. falciparum infection. LRIM1 was
originally identified as a powerful mediator of parasite killing in
a rodent malaria model but later shown to have little observable
effect on P. falciparum [31,32]. Our data indicate that LRIM1 does
contribute to the anti-P. falciparum response, but only at medium
levels of infection intensity (with a trending but non-significant
effect at low intensity) (Figure 5). We believe that the discrepancy
between our studies can be explained by the fact that the study
showing a lack of contribution of LRIM1 [32] was performed with
a different mosquito species and a field P.falciparum infection model
that generated a low infection intensity (indeed, in our exper-
iments, LRIM1 did not display anti-Plasmodium activity at low
infection intensity). The fact that LRIM1 has been linked to the
TEP1/APL1 anti-Plasmodium mechanism [33,34] suggests that it is
very likely to play a role in anti-Plasmodium activity, but it is
possible that it may not be required (or is redundant) at very low
infection intensities, or that RNAi-mediated depletion is not be
sufficient to reduce it to a level that would have any impact on a
low-intensity infection.
Third, the fact that caspar silencing had an effect at very high
infection intensity whereas Imd silencing did not may suggest that
other branches of the Imd pathway act upstream of Caspar and in
parallel with the Imd receptor. The existence of multiple
downstream signal circuits would also explain the robustness of
the caspar silencing phenotype and the variety of downstream
effectors it regulates. However, the identities of such circuits are
unknown.
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falciparum-laden blood meal, silencing caspar still greatly reduced
the resulting oocyst infection and, conversely, silencing tep1
significantly increased the infection. These results suggest that
these two components are essential factors in the anti-Plasmodium
defense for which no substitutes are allowed, whereas the other
factors may be to some degree redundant.
Taken together, our finding suggest that members of the Imd
pathway are reasonable first targets for vector-based malaria
control interventions, and analyses of such interventions should
necessarily include facets of mosquito-parasite infection biology
such as the level of the infection and the parasite stage(s) affected.
Clearly, some pathway members would be more effective than
others: Specifically, Imd, CaspL1, or REL2 would be good
positive regulators to manipulate, along with Caspar as the
negative regulator, and we have confirmed this conclusion for
REL2 using transgenic methodology [10]. The target should be
affected (a positive regulator enhanced or negative regulator
repressed) within the first 24 after feeding to have the greatest
effect on the ookinete stage, and the treatment could be more
effective if it were designed to prolong the enhancement/
repression through to the pre-oocyst stage. The fact that the
mature oocyst stage was marginally affected by the Imd pathway
means that an enhancement/repression lasting longer than 3 to 4
days post-feeding may be unnecessary but beneficial; this timing
would be amenable to adjustment in order to compensate for a low
impact on mosquito fitness. In a laboratory setting, transient
activation of the Imd pathway (via RNAi or caspar and transgenic
over-expression of REL2) has no observable impact on mosquito
fitness, yet is potently anti-parasitic [4,10]. A similar observation
has previously been made in the fruitfly Drosophila [35]. Moreover,
an Imd pathway-based intervention could also be successful,
regardless of the status of the endogenous bacteria; such an
approach would avoid potential species- or environment-specific
pitfalls, and yet the target of the intervention would be able to
effectively kill the parasite even at low levels of infection.
Components of the immune response of the mosquito vector of
Plasmodium have emerged as favorable candidates for targeted
malaria-control interventions. However, the immense technical
effort required to build such interventions is not trivial, and
therefore the preliminary refinement of candidate selection must
be thorough. Here we present data that not only identify the
biological mediators of the Imd pathway-driven immune response
that can render mosquitoes almost completely refractory to P.
falciparum but also answer major questions about when and how
that response is generated. We show that while several members of
the Imd pathway are critical for such a response, others are
indispensable, and the anti-Plasmodium response decreases in
potency as the parasite matures, with the pre-oocyst stages being
most vulnerable and the mature oocyst stage the least. We also
show that caspar-mediated refractoriness can occur without regard
to microbial flora or the intensity of the Plasmodium exposure,
revealing the delicate yet robust control this negative regulator
exerts over the Imd pathway and indicating the pathway’s
potential for broad applicability.
Materials and Methods
Ethics statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Animal Care and Use Committee of
the Johns Hopkins University (Permit Number: M006H300).
Commercial anonymous human blood was obtained from
Interstate Bloodbank and used for parasite cultures and mosquito
feeding and informed consent was therefore not applicable. The
Johns Hopkins School of Public Health Ethics Committee has
approved this protocol.
Mosquito rearing
Keele strain A. gambiae mosquito larvae were raised in
30634 cm trays (,250 larvae per tray) with cat food pellets
added daily and ground fish food supplemented upon water
change. Adults were reared in a 20620620 cm
3 cage and
sustained using a 10% sugar solution at 27uC and 80% humidity
with a 12-h light/dark cycle according to standard procedures
[36].
RNAi gene silencing
Assays were performed according to a standard protocol [37].
Genes encoding previously identified genes of the Anopheles Imd
pathway response and genes encoding 1-to-1 orthologs of Imd
components known in Drosphila were targeted by synthesizing
sense and antisense RNAs from ,300- to 600-bp PCR-amplified
gene fragments using the T7 Megascript kit (Ambion) and primers
indicated in Table S5. About 69 nl dsRNA (2–3 mg/ml) in water
was introduced into the thorax of cold-anesthetized 2- to 4-day-old
female mosquitoes using a nano-injector (Nanoject, Drummond)
with glass capillary needles according to Blandin et al. [38].
Double-silencing experiments were performed in the same
manner, except that dsRNAs targeting each gene were mixed
and concentrated so that each dsRNA was present at 2–3 mg/ml.
Depletion of dsRNA targets after silencing was quantified;
silencing efficiencies are given in Table S5.
Infection with Plasmodium
Mosquitoes were fed on NF54 gametocytes in human blood
through a membrane feeder at 37uC at various time points,
depending on the stage being examined: 3–4 days after dsRNA
injection for assessment of ookinetes (Figures 2, 4, and 5), 2 days
prior to dsRNA injection for early oocysts (Figure 3B), and 6 days
prior to dsRNA injection for late oocysts (Figure 3C), and at
various dilutions for high-, medium- and low-infection exposures.
All mosquitoes were subsequently maintained at 24uC until 7 to 8
days post-feeding, when midguts were dissected and stained with
0.1% mercurochrome in PBS, and oocyst numbers were recorded
using light microscopy (Olympus). Each assay was done with at
least 25 mosquitoes, and data represent the results of at least three
independent assays. P-values were determined using Mann-
Whitney tests; further statistical analysis was performed using
Fisher’s Exact test and Kruskal-Wallis tests with Dunn’s Multiple
Comparison Summary (Tables S1, S2, S3, S4).
Time course analysis and real-time quantitative PCR
expression analysis
Mosquitoes were silenced for caspar or GFP (as a control) 2 days
after emergence and incubated under normal conditions. Each
day at the same time, ,10 mosquitoes from each group were
collected and homogenized for total RNA extraction. Assays were
then performed according to a standard protocol [37]. Total RNA
from adult females was extracted using the RNeasy kit (QIAGEN),
quantified using a Beckman DU640 spectrophotometer, and
subjected to reverse transcription using Superscript III (Invitrogen)
with random hexamers. Real-time quantification was performed
using the QuantiTect SYBR Green PCR Kit (Qiagen) and ABI
Detection System ABI Prism 7000. Primer sequences are given in
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verify the specificity of the PCR reactions, melting curves were
obtained for each data point. The levels of expression in gene-
silenced samples were determined by normalizing the cDNA levels
using the ribosomal protein S7 gene and compared to controls
treated with dsRNA against GFP.
Antibiotic treatment assays
Groups of 80–100 recently emerged (.1-day-old) female A.
gambiae mosquitoes were sequestered in pint-capacity paper cups
and maintained on either 10% sucrose or 10% sucrose supple-
mented with 10 mg/mL penicillin-streptomycin and 15 mg/mL
gentamicin [9]. For each replicate, 5–10 midguts from each group
were dissected and homogenized in PBS, and serial dilutions were
plated on LB agar to confirm a 1,000-fold reduction in bacterial
loads when antibiotics were administered in the sucrose solution.
Comparisons of antibiotic-treated and untreated mosquitoes
utilized the Plasmodium infection, RNA extraction, PCR amplifi-
cation, and other methods described above. Primer sequences are
given in Table S5.
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